http://www.futureprescriber.co.uk Future Prescriber news RSS Feed http://www.futureprescriber.co.uk/details/news/765143/Firstinclass_approved_for_COPD.html Nycomed’s novel anti-inflammatory roflumilast will soon be available in the EU following a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use. 2010-07-30T15:36:00Z http://www.futureprescriber.co.uk/details/news/765141/New_cancer_drug_targets_microtubules.html Data presented at the American Association of Cancer Research Annual Meeting in Washington DC show that Basilea’s novel small molecule anticancer drug BAL 101553 is potentially effective against a wide range of tumour types, including some resistant to chemotherapy. 2010-07-30T15:35:00Z http://www.futureprescriber.co.uk/details/news/765139/More_on_cladribine_in_multiple_sclerosis.html Further analysis of the CLARITY trial has provided more information about the effectiveness of the lymphocyte-depleting agent cladribine in the treatment of multiple sclerosis. 2010-07-30T15:34:00Z http://www.futureprescriber.co.uk/details/news/765137/New_treatment_target_for_autoimmune_disease.html Researchers at Leicester University have discovered a new mechanism regulating B-cell activation that could open the way for new treatments for autoimmune diseases (Nature 2010;11:265–72). 2010-07-30T15:32:00Z http://www.futureprescriber.co.uk/details/news/765135/Pitavastatin_efficacy.html Kowa’s new statin maintains reductions in LDL-cholesterol (LDL-C) during a year’s treatment with no evidence of new adverse events. 2010-07-30T15:31:00Z